While increased IGF1 levels as well as constitutive activation of the IGF1R are important risk factors in cancer, reduced activities of the GHR, IGF1R, insulin receptor and downstream mediators (e.g., AKT, mTOR, FOXO) have been associated with a prolonged lifespan (49). This evidence concerns the gene IGF1 and cancer.